Chemtura Corporation (NYSE: CEM; the "Company”)
reports net earnings of $11 million, or $0.05 per share, for the third
quarter of 2008 and net earnings on a managed basis of $26 million, or
$0.11 per share for the quarter.
The discussion below includes information on both a GAAP and managed
basis. The Company presents managed basis financial information as
management uses this information internally to evaluate and direct the
performance of the Company’s operations and
believes that the managed basis financial information provides useful
information to investors. A reconciliation of GAAP and managed basis
financial information is provided in the supplemental schedules included
in this release.
The following is a summary of third
quarter results on a GAAP basis:
|
(In millions, except per share data)
|
|
Third Quarter
|
|
|
|
|
2008
|
|
|
2007
|
|
|
% change
|
|
|
Net sales
|
|
$
|
924
|
|
$
|
929
|
|
|
(1
|
)%
|
|
Operating profit
|
|
$
|
44
|
|
$
|
23
|
|
|
91
|
%
|
|
Earnings from continuing operations
|
|
$
|
11
|
|
$
|
1
|
|
|
NM
|
|
|
Earnings per share from continuing operations
|
|
$
|
0.05
|
|
$
|
0.01
|
|
|
NM
|
|
|
Earnings per share from discontinued operations
|
|
$
|
-
|
|
$
|
0.01
|
|
|
NM
|
|
|
Per share loss on sale of discontinued operations
|
|
$
|
-
|
|
$
|
(0.01
|
)
|
|
NM
|
|
|
Net earnings per share
|
|
$
|
0.05
|
|
$
|
0.01
|
|
|
NM
|
|
NM = Not Meaningful
The following is a summary of third
quarter results on a managed basis:
|
(In millions, except per share data)
|
|
Third Quarter
|
|
|
|
|
2008
|
|
|
2007
|
|
% change
|
|
|
Net sales
|
|
$
|
924
|
|
$
|
929
|
|
(1
|
)%
|
|
Operating profit
|
|
$
|
57
|
|
$
|
52
|
|
10
|
%
|
|
Earnings from continuing operations
|
|
$
|
26
|
|
$
|
16
|
|
63
|
%
|
|
Earnings per share from continuing operations
|
|
$
|
0.11
|
|
$
|
0.07
|
|
57
|
%
|
|
Earnings per share from discontinued operations
|
|
$
|
-
|
|
$
|
0.01
|
|
NM
|
|
|
Net earnings per share
|
|
$
|
0.11
|
|
$
|
0.08
|
|
38
|
%
|
NM = Not Meaningful
"This quarter we delivered our fourth
consecutive quarter of year-over-year improvement in managed basis
earnings. Those earnings were $0.11 per share, representing a 57 percent
increase compared to last year’s third
quarter. We achieved those results in spite of the largest year-on-year
increase in raw material costs that we have seen, a soft conclusion to
what has been a disappointing pool season and the impact of disruptions
from Gulf Coast hurricanes. All in all, it was a quarter of continued
progress,” said Robert L. Wood, Chemtura
chairman and CEO.
"Our strongest businesses, Crop Protection and
Performance Specialties, continue to deliver excellent results with
operating income up 64 percent and 11 percent, respectively over prior
year performance.
"We continue to have confidence in our
Consumer business. Even though operating income declined in the quarter
compared to last year, we were able to maintain strong relationships
with the key customers in our most important channels, as well as
increase selling prices. However, this was not enough to overcome higher
input costs, freight fuel surcharges and what proved to be one of the
weakest pool seasons in recent years. After a cold and wet start in
North America and inventory overhangs in Europe from the 2007 floods, we
saw a slow end to the season, partially due to the uncertainty about the
economy that is constraining consumer spending. Nonetheless, the
business is sound and we expect the 2009 season to benefit from the
increases in selling prices.
"Despite improvement in some areas, Polymer
Additives’ operating profit, on a managed
basis, declined 13 percent compared to the third quarter of 2007.
Although there was positive demand for clear brine fluids used in
drilling applications, the combination of lower sales in plastic
antioxidants, disruptions from the Gulf Coast hurricanes, slowing demand
for flame retardant products – particularly
in electronics applications, and a relentless rise in raw material and
energy costs was more than the business could overcome in the quarter,”
Wood said.
"Overall, raw material costs for the quarter
increased $67 million, the highest quarterly increase in quite some
time. In response, selling prices were up year-on-year by $59 million,
also a new high. Our initiatives to increase the speed with which we
pass on changes in raw material costs are delivering results, reducing
the gap between changes in raw material costs and selling prices to only
$8 million in the third quarter, the best performance this year.
"In recent weeks, we all have seen the spot
prices of key commodities start to fall. While it can take some time for
such changes to work their way down the supply chain, we should start to
see some relief in raw material costs later in the fourth quarter. With
manufacturing cycle times and inventory effects, it will likely be the
first quarter 2009 before we see sequential improvement in our costs of
goods sold. Improvements in year-on-year comparisons may take longer, as
raw material costs must fall significantly before they are below the
costs seen in the first and second quarters of 2008.
"We have benefited from the restructuring
actions taken in 2007. On a managed basis, SGA&R expenses were down 13
percent or $13 million from the third quarter of 2007, and overall
operating profit for the third quarter increased $5 million, or 10
percent compared with prior year,” Wood said.
"Chemtura is now tightly focused on
performance in the fourth quarter 2008 and the implications and outlook
for 2009. Like most companies, we are assessing how our company will be
specifically affected by the credit crisis and the changes in the
macroeconomic outlook for the global economy. Many of our customers are
beginning to anticipate reduced demand in 2009, and some are already
reducing their requirements.
"Chemtura’s four
businesses serve the needs of a diverse set of industries, each with
different exposures to macroeconomic changes. For example, the
electronics market has seen demand soften as the year has progressed,
and now, in the fourth quarter, we are seeing customers in the Asian
region take actions to reduce production and de-stock inventories.
Meanwhile our Petroleum Additives business has continued to grow,
despite higher oil prices and lower new build automobile production. In
building and construction applications, we have seen end-market demand
soften for at least four quarters, nonetheless, we have been able to
offset much of the impact through co-producer deals and the diversity of
the applications we serve. It is too soon to have a definitive view of
demand in 2009; therefore our focus is on sustaining cash flow and
profitability should demand from certain industries declines.
Wood advised, "We enter this period of
economic uncertainty with significant liquidity. As of September 30,
2008, we had $107 million in cash on hand, revolver availability of
approximately $580 million and additional capacity under our accounts
receivable securitization programs. We are comfortably in compliance
with our revolver financial maintenance covenants as of September 30,
2008. Nevertheless, with the uncertainty in the financial markets we
have implemented a five-point plan to reinforce further our ability to
weather continued difficult conditions. We believe our shareholders will
agree that with the pending maturity in July 2009 of our 7 percent 2009
senior notes of $370 million, the Company should maximize our options to
address that maturity. If market conditions permit, we will refinance
these notes by issuance of a new security or redeem the notes with the
proceeds from an asset sale, if one were to occur. However, if financial
market conditions remain difficult, we will refinance these notes from
our other sources of liquidity, such as our revolver, until such time as
we can complete a refinancing transaction. The specific components of
our five-point plan to improve our liquidity even further are as follows:
-
We are reducing inventories to free up meaningful cash reserves,
though this may cause some cost absorption effects in some of our
plants and result in manufacturing variances in the fourth quarter
2008 and first quarter 2009.
-
We have decreased our planned 2008 capital spending by $25 million and
are re-evaluating our spending plans for 2009.
-
In line with our announcement on June 26, 2008, we continue to
actively evaluate strategic options, including (among other options)
select business divestitures, value creating acquisitions, joint
ventures and changes in the Company’s
capital structure. Despite macroeconomic uncertainties, we continue to
make progress on these efforts with the primary focus on the
divestiture of a business. We have a financial advisor assisting us in
this process. However, given the current economic climate, we
recognize that it may take longer to conclude a transaction.
-
We will maintain tight control on discretionary spending and take
appropriate steps to rationalize capacity as demand dictates.
-
We are suspending the payment of our dividend as a prudent measure to
further increase liquidity and to increase our financial flexibility.
Wood concluded, "By taking these steps to
further expand our liquidity, we remain confident that we will satisfy
our debt maturity obligation and continue building our enterprise.”
Third Quarter 2008 Business Segment Highlights
-
Crop Protection continued to benefit from global demand for produce
and generally good growing conditions around the world. Revenues
increased 24% or $20 million compared with the third quarter of 2007
driven by increased volumes in Europe and Latin America. Because of
the specialty, niche focus of our portfolio, unlike larger
agricultural companies, we have limited exposure to agricultural
demand pulled by bio-diesel or large volume crops. Operating profit
rose 64% or $7 million in the third quarter as compared with the same
quarter of 2007, driven mainly by the margin impact of higher sales
volumes.
-
Performance Specialties is well positioned in the value chain for
lubricants and versatile urethane products. Revenue grew by 14% or $34
million and operating profit increased 11% or $3 million compared with
the third quarter of 2007. The revenue growth was primarily due to
higher selling prices of $28 million, increased sales volumes of $3
million and favorable foreign currency translation of $3 million.
Operating profit benefited from higher selling prices and improved
product mix, which in the aggregate offset increased raw material,
energy, manufacturing and freight costs.
-
Polymer Additives’ revenues decreased by 7%
or $33 million compared with the third quarter of 2007, which included
a $45 million reduction from the divestiture of the oleochemicals and
organic peroxides businesses. Sales volume decreased by $21 million,
primarily related to lower sales in plastic antioxidants. These
reductions were partially offset by higher selling prices of $25
million, improved mix and favorable foreign currency translation of $8
million. The hurricanes that hit the Gulf Coast in early September
resulted in our Taft, Louisiana facility being closed for four days.
The negative impact on operating income for the quarter due to the
hurricanes was approximately $3 million. As a result, operating profit
on a managed basis was 13% or $2 million lower than the third quarter
of 2007. On a GAAP basis, operating profit increased $7 million as
compared with the third quarter of 2007, primarily due to lower
depreciation expense.
-
Consumer Products’ revenues declined 13% or
$18 million compared with the third quarter of 2007 mainly due to
lower volumes. The $27 million decline in sales volumes was due to the
soft conclusion of the 2008 pool season and lower European demand
compared with the third quarter of 2007. These impacts were partially
offset by higher selling prices of $7 million and the benefit of
favorable foreign currency translation of $2 million. As a result,
operating profit declined 20% or $4 million.
-
Corporate expense for the quarter was $25 million compared with $24
million in the prior year. Corporate expense included amortization
expense related to intangibles of $10 million and $11 million for the
third quarter ended 2008 and 2007, respectively.
Third Quarter Results - GAAP
-
Revenue for the quarter was $924 million compared with third quarter
2007 revenue of $929 million. The decrease in revenue was attributable
to $63 million from the impact of the divestitures, primarily related
to the sale of the oleochemicals business, organic peroxides business,
and Terraclor product line and $16 million from decreased volume and
product mix. The decrease was partially offset by $59 million from
higher selling prices and $15 million from favorable foreign currency
translation.
-
Third quarter 2008 gross profit was $193 million, or 21% of sales, as
compared with third quarter 2007 gross profit of $202 million, or 22%
of sales. The $9 million decrease in gross profit resulted from $67
million in higher raw material and energy costs, $5 million from
divestitures and $1 million from product mix, offset by $59 million
from higher selling prices and $5 million from favorable foreign
currency translation.
-
The operating profit for the third quarter of 2008 was $44 million,
compared with a profit of $23 million for the third quarter of 2007.
The increase in operating profit reflects a $10 million decrease in
SGA&R (selling, general and administrative, and research and
development) costs due to savings from the 2007 restructuring program
and cost-reduction initiatives. Operating profit also benefited from a
$9 million decrease in facility closures, severance and related costs;
an $8 million decrease in impairment of long-lived assets (2007
included a $9 million impairment related to the Company’s
Ravenna, Italy facility); and a $5 million decrease in depreciation
and amortization primarily due to lower accelerated depreciation of
property, plant and equipment. These favorable impacts were partially
offset by a $9 million decrease in gross profit discussed above and a
$2 million decrease due to loss on the sale of business.
-
Other income increased by $11 million in the third quarter of 2008 as
compared with the same quarter last year. The increase primarily
reflects an increase in foreign exchange gains, higher interest income
and a decrease in minority interest expense.
-
Earnings from continuing operations for the third quarter of 2008 were
$11 million, or $0.05 per share, compared with earnings of $1 million,
or $0.01 per share, for the third quarter of 2007. The increase
primarily reflects the $21 million increase in operating profit
discussed above, an $11 million increase in other income, net and a $1
million decrease in interest expense, partially offset by a $23
million increase in income tax expense.
-
Earnings from discontinued operations for the third quarter of 2007
were $3 million (net of $2 million of tax) and primarily reflect the
contribution from the fluorine and optical monomers businesses that
were subsequently sold.
-
In the third quarter of 2007, the loss on the sale of discontinued
operations of $2 million (net of $1 million of tax) related to the
sale of the EPDM business.
Third Quarter Results - Managed Basis
-
On a managed basis, third quarter 2008 gross profit was $192 million,
or 21% of net sales, as compared with third quarter 2007 managed basis
gross profit of $202 million, or 22% of net sales. Increases in raw
material prices are the primary drivers in the reduction in margin
percentage.
-
On a managed basis, third quarter 2008 operating profit was $57
million, as compared with third quarter 2007 managed basis operating
profit of $52 million. The increase in operating profit primarily
reflects decreases in SGA&R costs due to cost reduction initiatives
partially offset by gross profit reductions.
-
Earnings from continuing operations before income taxes on a managed
basis in 2008 and 2007 exclude pre-tax charges of $13 million and $29
million, respectively. These charges are primarily related to
accelerated depreciation of property, plant and equipment; facility
closures, severance and related costs; antitrust costs; loss (gain) on
sale of businesses; impairment of long-lived assets; accelerated
recognition of asset retirement obligations; insurance recovery
related to a fire at the Company’s Conyers,
Georgia facility; and pension curtailment and settlement adjustments
associated with international pension plans.
-
Chemtura’s managed basis tax rate of 35%
represents the expected effective tax rate for the Company’s
core operations. The Company has chosen to apply this rate to pre-tax
income on a managed basis to better reflect underlying operating
performance.
-
Earnings from discontinued operations on a managed basis of $3 million
for the quarter ended September 30, 2007 reflect the contribution of
the optical monomers and fluorine businesses.
Cash Flows - GAAP
-
Net cash provided by operations in the quarter ended September 30,
2008 was $68 million as compared with $124 million in 2007.
-
As of September 30, 2008, the Company’s
accounts receivable balances before securitization were $601 million
as compared with $750 million as of June 30, 2008. The decrease was
primarily due to seasonality reduction in receivables for the
Consumers Products business, the strengthening of the U.S. Dollar and
the benefit of Company’s collection efforts.
-
As of September 30, 2008, the Company’s
inventory balance was $720 million as compared with $727 million at
June 30, 2008. The decrease was primarily due to the strengthening of
the U.S. dollar. As of September 30, 2008, the increase in raw
material prices had increased the carrying value of our inventories by
approximately $50 million since the start of the year. The Company is
targeting to reduce its inventories in the fourth quarter of 2008 and
in 2009.
-
Capital expenditures for the quarter ended September 30, 2008 were $35
million compared with $27 million in 2007. In light of the demand
outlook, the Company has reduced its anticipated capital expenditures
for the calendar year 2008 from its original estimate of $165 million
to approximately $140 million. These expenditures include
approximately $28 million related to the consolidation of its legacy
ERP systems onto a single instance of SAP.
-
The Company’s total debt as of September
30, 2008 was $1,096 million as compared with $1,115 million as of June
30, 2008. Cash and cash equivalents were $107 million as of September
30, 2008 compared to $110 million as of June 30, 2008.
Third Quarter Earnings Q&A Teleconference
Copies of this release, as well as informational slides, will be
available on the Investor Relations section of the Company’s
Web site at www.chemtura.com.
The Company will host a teleconference to review these results on
Friday, October 31, at 9 a.m. EDT. Interested parties are asked to dial
in approximately 10 minutes prior to the start time. The call-in number
is (702) 696-4881. Replay of the call will be available for two weeks,
starting at noon EDT on Friday, October 31, 2008. To access the replay,
call (706) 645-9291 and enter access code 68071478.
Live Internet access to the 2008 third quarter conference call will be
available through the Investor Relations section of the Company’s
Web site. If you need further information pertaining to the call, please
contact Shirley Cronan at (203) 573-2213.
Chemtura Corporation, with 2007 sales of $3.7 billion, is a global
manufacturer and marketer of specialty chemicals, crop protection and
pool, spa and home care products. Additional information concerning
Chemtura is available at www.chemtura.com.
Managed Basis Financial Measures
The information presented in this press release and in the attached
financial tables includes financial measures that are not calculated or
presented in accordance with Generally Accepted Accounting Principles in
the United States (GAAP).
These managed basis financial measures
consist of adjusted results of operations of the Company that exclude
certain expenses, gains and losses that may not be indicative of the
core operations of the Company.
Excluded items include facility
closures, severance and related costs, antitrust costs, merger costs,
increased depreciation due to the change in useful life of assets,
unusual and non-recurring settlements, accelerated recognition of asset
retirement obligations and impairment of long-lived assets. In addition
to the managed basis financial measures discussed above, the Company has
applied a managed basis effective income tax rate to our managed basis
income before taxes. Chemtura’s managed basis
tax rate of 35%, beginning with the third quarter of 2007, represents
the expected effective tax rate for the Company’s
core operations. Reconciliations of these managed basis financial
measures to their most directly comparable GAAP financial measures are
provided in the attached financial tables.
The Company believes
that such managed basis financial measures provide useful information to
investors and may assist them in evaluating the Company’s
underlying performance and identifying operating trends.
In
addition, management uses these managed basis financial measures
internally to allocate resources and evaluate the performance of the
Company’s operations.
While the
Company believes that such measures are useful in evaluating the Company’s
performance, investors should not consider them to be a substitute for
financial measures prepared in accordance with GAAP.
In addition,
these managed basis financial measures may differ from similarly titled
managed basis financial measures used by other companies and do not
provide a comparable view of the Company's performance relative to other
companies in similar industries.
Forward-Looking Statement
This document includes forward-looking statements.
These
forward-looking statements are identified by terms and phrases such as "anticipate,”
"believe,”
"intend,”
"estimate,”
"expect,”
"continue,”
"should,”
"could,”
"may,”
"plan,”
"project,”
"predict,”
"will”
and similar expressions and include references to assumptions and relate
to our future prospects, developments and business strategies.
Factors that could cause our actual results to differ materially from
those expressed or implied in such forward-looking statements include,
but are not limited to:
-
General economic conditions;
-
Significant international operations and interests;
-
The ability to obtain increases in selling prices to offset
increases in raw material and energy costs;
-
The ability to retain sales volumes in the event of increasing
selling prices;
-
The ability to absorb fixed cost overhead in the event of lower
volumes;
-
Pension and other post-retirement benefit plan assumptions;
-
The ability to successfully complete the turnaround of our Polymer
Additives segment;
-
The ability to obtain growth from demand for petroleum additive,
lubricant and agricultural product applications;
-
The ability to sustain profitability in our Crop Protection
business due to new generic competition. Additionally, the Crop
Protection business is dependent on disease and pest conditions, as
well as local, regional, regulatory and economic conditions;
-
The ability to sell methyl bromide due to regulatory restrictions;
-
Changes in weather conditions which could adversely affect the
seasonal selling cycles in both our Consumer Products and Crop
Protection segments;
-
Changes in the availability and/or quality of our energy and raw
materials;
-
The ability to collect our outstanding receivables;
-
Changes in interest rates and foreign currency exchange rates;
-
Changes in technology, market demand and customer requirements;
-
The enactment of more stringent domestic and international
environmental laws and regulations;
-
The ability to realize expected cost savings under our
restructuring plans, Six Sigma and Lean manufacturing initiatives;
-
The ability to maintain effective collective bargaining agreements
with union employees;
-
The outcome of our review of strategic alternatives including our
ability to sell a business or assets as part of a portfolio
re-alignment;
-
The ability to reduce our indebtedness levels;
-
The ability to reduce inventories in the fourth quarter of 2008 and
in 2009;
-
The ability to refinance our debt obligations as they near maturity;
-
The ability to recover our deferred tax assets;
-
The ability to successfully complete the Company’s
new SAP platform initiative;
-
The ability to support the goodwill related to our business
segments if they sustain a decline in demand or percentage margins;
-
The ability to remain compliant with our debt covenants or obtain
necessary waivers; and
-
Other risks and uncertainties detailed in Item 1A. Risk Factors or
in our filings with the Securities and Exchange Commission.
These statements are based on the Company’s
estimates and assumptions and on currently available information. The
forward-looking statements include information concerning the Company’s
possible or assumed future results of operations, and the Company’s
actual results may differ significantly from the results discussed.
Forward-looking
information is intended to reflect opinions as of the date this press
release was issued and such information will not necessarily be updated
by the Company.
|
CHEMTURA CORPORATION
|
|
|
Index of Financial Statements and Schedules
|
|
|
|
Page
|
|
|
|
|
Financial Statements
|
|
|
|
|
|
Consolidated Statements of Operations (Unaudited) -
|
|
|
Quarter and Nine Months ended September 30, 2008 and 2007
|
10
|
|
|
|
|
Consolidated Balance Sheets - September 30, 2008 (Unaudited) and
|
|
|
December 31, 2007
|
11
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows (Unaudited) -
|
|
|
Nine Months ended September 30, 2008 and 2007
|
12
|
|
|
|
|
Segment Net Sales and Operating Profit (Loss) (Unaudited) -
|
|
|
Quarter and Nine Months ended September 30, 2008 and 2007
|
13
|
|
|
|
|
Supplemental Schedules
|
|
|
|
|
|
Major Factors Affecting Net Sales and Operating Results
(Unaudited) -
|
|
|
Quarter and Nine Months ended September 30, 2008 versus 2007
|
14
|
|
|
|
|
Managed Basis Consolidated Statements of Operations (Unaudited) -
|
|
|
Quarter ended September 30, 2008 and 2007
|
15
|
|
|
|
|
Managed Basis Consolidated Statements of Operations (Unaudited) -
|
|
|
Nine Months ended September 30, 2008 and 2007
|
16
|
|
|
|
|
Managed Basis Segment Net Sales and Operating Profit (Loss)
(Unaudited) -
|
|
|
Quarter ended September 30, 2008 and 2007
|
17
|
|
|
|
|
Managed Basis Segment Net Sales and Operating Profit (Loss)
(Unaudited) -
|
|
|
Nine Months ended September 30, 2008 and 2007
|
18
|
|
CHEMTURA CORPORATION
|
|
|
|
|
|
Consolidated Statements of Operations (Unaudited)
|
|
(In millions, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended
|
|
|
Nine Months Ended
|
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
|
2008
|
|
|
|
2007
|
|
|
|
2008
|
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
924
|
|
|
$
|
929
|
|
|
$
|
2,856
|
|
|
$
|
2,856
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold
|
|
|
731
|
|
|
|
727
|
|
|
|
2,231
|
|
|
|
2,197
|
|
|
Selling, general and administrative
|
|
|
80
|
|
|
|
87
|
|
|
|
253
|
|
|
|
292
|
|
|
Depreciation and amortization
|
|
|
54
|
|
|
|
59
|
|
|
|
180
|
|
|
|
192
|
|
|
Research and development
|
|
|
12
|
|
|
|
15
|
|
|
|
40
|
|
|
|
46
|
|
|
Facility closures, severance and related costs
|
|
|
-
|
|
|
|
9
|
|
|
|
-
|
|
|
|
34
|
|
|
Antitrust costs
|
|
|
1
|
|
|
|
2
|
|
|
|
12
|
|
|
|
32
|
|
|
Loss (gain) on sale of business
|
|
|
1
|
|
|
|
(1
|
)
|
|
|
25
|
|
|
|
14
|
|
|
Impairment of long-lived assets
|
|
|
1
|
|
|
|
9
|
|
|
|
321
|
|
|
|
16
|
|
|
Equity income
|
|
|
-
|
|
|
|
(1
|
)
|
|
|
(3
|
)
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit (loss)
|
|
|
44
|
|
|
|
23
|
|
|
|
(203
|
)
|
|
|
35
|
|
|
Interest expense
|
|
|
(20
|
)
|
|
|
(21
|
)
|
|
|
(59
|
)
|
|
|
(67
|
)
|
|
Other income (expense), net
|
|
|
4
|
|
|
|
(7
|
)
|
|
|
16
|
|
|
|
(11
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) from continuing operations before income taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28
|
|
|
|
(5
|
)
|
|
|
(246
|
)
|
|
|
(43
|
)
|
|
Income tax (expense) benefit
|
|
|
(17
|
)
|
|
|
6
|
|
|
|
(37
|
)
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) from continuing operations
|
|
|
11
|
|
|
|
1
|
|
|
|
(283
|
)
|
|
|
(42
|
)
|
|
Earnings from discontinued operations
|
|
|
-
|
|
|
|
3
|
|
|
|
-
|
|
|
|
14
|
|
|
(Loss) gain on sale of discontinued operations
|
|
|
-
|
|
|
|
(2
|
)
|
|
|
-
|
|
|
|
25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings (loss)
|
|
$
|
11
|
|
|
$
|
2
|
|
|
$
|
(283
|
)
|
|
$
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted earnings (loss) per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) from continuing operations
|
|
$
|
0.05
|
|
|
$
|
0.01
|
|
|
$
|
(1.17
|
)
|
|
$
|
(0.17
|
)
|
|
Earnings from discontinued operations
|
|
|
-
|
|
|
|
0.01
|
|
|
|
-
|
|
|
|
0.06
|
|
|
(Loss) gain on sale of discontinued operations
|
|
|
-
|
|
|
|
(0.01
|
)
|
|
|
-
|
|
|
|
0.10
|
|
|
Net earnings (loss)
|
|
$
|
0.05
|
|
|
$
|
0.01
|
|
|
$
|
(1.17
|
)
|
|
$
|
(0.01
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - basic and diluted
|
|
|
242.4
|
|
|
|
241.9
|
|
|
|
242.3
|
|
|
|
241.4
|
|
|
CHEMTURA CORPORATION
|
|
|
|
Consolidated Balance Sheets
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
|
December 31,
|
|
|
|
|
2008
|
|
|
2007
|
|
ASSETS
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT ASSETS
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
107
|
|
|
$
|
77
|
|
|
Accounts receivable
|
|
|
287
|
|
|
|
389
|
|
|
Inventories
|
|
|
720
|
|
|
|
676
|
|
|
Other current assets
|
|
|
212
|
|
|
|
239
|
|
|
Total current assets
|
|
|
1,326
|
|
|
|
1,381
|
|
|
|
|
|
|
|
|
|
|
NON-CURRENT ASSETS
|
|
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
923
|
|
|
|
1,032
|
|
|
Goodwill
|
|
|
943
|
|
|
|
1,309
|
|
|
Intangible assets, net
|
|
|
537
|
|
|
|
585
|
|
|
Other assets
|
|
|
150
|
|
|
|
109
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,879
|
|
|
$
|
4,416
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES
|
|
|
|
|
|
|
|
Short-term borrowings
|
|
$
|
4
|
|
|
$
|
5
|
|
|
Accounts payable
|
|
|
261
|
|
|
|
285
|
|
|
Accrued expenses
|
|
|
301
|
|
|
|
353
|
|
|
Income taxes payable
|
|
|
66
|
|
|
|
38
|
|
|
Total current liabilities
|
|
|
632
|
|
|
|
681
|
|
|
|
|
|
|
|
|
|
|
NON-CURRENT LIABILITIES
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
1,092
|
|
|
|
1,058
|
|
|
Pension and post-retirement health care liabilities
|
|
|
322
|
|
|
|
361
|
|
|
Other liabilities
|
|
|
351
|
|
|
|
463
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
|
Common stock
|
|
|
3
|
|
|
|
3
|
|
|
Additional paid-in capital
|
|
|
3,036
|
|
|
|
3,028
|
|
|
Accumulated deficit
|
|
|
(1,499
|
)
|
|
|
(1,179
|
)
|
|
Accumulated other comprehensive income
|
|
|
109
|
|
|
|
168
|
|
|
Treasury stock at cost
|
|
|
(167
|
)
|
|
|
(167
|
)
|
|
Total stockholders' equity
|
|
|
1,482
|
|
|
|
1,853
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,879
|
|
|
$
|
4,416
|
|
|
CHEMTURA CORPORATION
|
|
Condensed Consolidated Statements of Cash Flows (Unaudited)
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
Increase (decrease) to cash
|
|
|
2008
|
|
|
|
2007
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(283
|
)
|
|
$
|
(3
|
)
|
|
Adjustments to reconcile net loss to net cash provided by operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on sale of business
|
|
|
25
|
|
|
|
14
|
|
|
Gain on sale of discontinued operations
|
|
|
-
|
|
|
|
(25
|
)
|
|
Impairment of long-lived assets
|
|
|
321
|
|
|
|
16
|
|
|
Depreciation and amortization
|
|
|
180
|
|
|
|
197
|
|
|
Stock-based compensation expense
|
|
|
6
|
|
|
|
8
|
|
|
Equity income, net of cash distributions
|
|
|
(3
|
)
|
|
|
(2
|
)
|
|
Changes in assets and liabilities, net
|
|
|
(152
|
)
|
|
|
(34
|
)
|
|
Net cash provided by operations
|
|
|
94
|
|
|
|
171
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
Net proceeds from divestments
|
|
|
68
|
|
|
|
157
|
|
|
Payments for acquisitions, net of cash acquired
|
|
|
(37
|
)
|
|
|
(164
|
)
|
|
Capital expenditures
|
|
|
(94
|
)
|
|
|
(73
|
)
|
|
Net cash used in investing activities
|
|
|
(63
|
)
|
|
|
(80
|
)
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
Proceeds from credit facility, net
|
|
|
70
|
|
|
|
-
|
|
|
Proceeds from long term borrowings
|
|
|
1
|
|
|
|
-
|
|
|
Payments on long term borrowings
|
|
|
(31
|
)
|
|
|
-
|
|
|
Payments on short term borrowings
|
|
|
-
|
|
|
|
(46
|
)
|
|
Dividends paid
|
|
|
(36
|
)
|
|
|
(36
|
)
|
|
Proceeds from exercise of stock options
|
|
|
1
|
|
|
|
7
|
|
|
Other financing activities
|
|
|
-
|
|
|
|
(1
|
)
|
|
Net cash provided by (used in) financing activities
|
|
|
(5
|
)
|
|
|
(76
|
)
|
|
|
|
|
|
|
|
|
|
CASH
|
|
|
|
|
|
|
|
Effect of exchange rates on cash and cash equivalents
|
|
|
(6
|
)
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents
|
|
|
30
|
|
|
|
19
|
|
|
Cash and cash equivalents at beginning of period
|
|
|
77
|
|
|
|
95
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
$
|
107
|
|
|
$
|
114
|
|
|
CHEMTURA CORPORATION
|
|
Segment Net Sales and Operating Profit (Loss) (Unaudited)
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended
|
|
|
Nine Months Ended
|
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
|
2008
|
|
|
|
2007
|
|
|
|
2008
|
|
|
|
2007
|
|
|
NET SALES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Polymer Additives
|
|
$
|
414
|
|
|
$
|
447
|
|
|
$
|
1,294
|
|
|
$
|
1,366
|
|
|
Performance Specialties
|
|
|
271
|
|
|
|
237
|
|
|
|
787
|
|
|
|
680
|
|
|
Consumer Products
|
|
|
121
|
|
|
|
139
|
|
|
|
422
|
|
|
|
456
|
|
|
Crop Protection
|
|
|
103
|
|
|
|
83
|
|
|
|
306
|
|
|
|
261
|
|
|
Other
|
|
|
15
|
|
|
|
23
|
|
|
|
47
|
|
|
|
93
|
|
|
Total Net Sales
|
|
$
|
924
|
|
|
$
|
929
|
|
|
$
|
2,856
|
|
|
$
|
2,856
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING PROFIT (LOSS)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Polymer Additives
|
|
$
|
14
|
|
|
$
|
7
|
|
|
$
|
49
|
|
|
$
|
64
|
|
|
Performance Specialties
|
|
|
31
|
|
|
|
28
|
|
|
|
88
|
|
|
|
82
|
|
|
Consumer Products
|
|
|
16
|
|
|
|
20
|
|
|
|
49
|
|
|
|
56
|
|
|
Crop Protection
|
|
|
18
|
|
|
|
11
|
|
|
|
63
|
|
|
|
40
|
|
|
Other
|
|
|
1
|
|
|
|
1
|
|
|
|
2
|
|
|
|
(3
|
)
|
|
|
|
|
80
|
|
|
|
67
|
|
|
|
251
|
|
|
|
239
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General corporate expense, including amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(25
|
)
|
|
|
(24
|
)
|
|
|
(72
|
)
|
|
|
(71
|
)
|
|
Accelerated depreciation of property, plant and equipment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8
|
)
|
|
|
(1
|
)
|
|
|
(24
|
)
|
|
|
(37
|
)
|
|
Facility closures, severance and related costs
|
|
|
-
|
|
|
|
(9
|
)
|
|
|
-
|
|
|
|
(34
|
)
|
|
Antitrust costs
|
|
|
(1
|
)
|
|
|
(2
|
)
|
|
|
(12
|
)
|
|
|
(32
|
)
|
|
(Loss) gain on sale of business
|
|
|
(1
|
)
|
|
|
1
|
|
|
|
(25
|
)
|
|
|
(14
|
)
|
|
Impairment of long-lived assets
|
|
|
(1
|
)
|
|
|
(9
|
)
|
|
|
(321
|
)
|
|
|
(16
|
)
|
|
Total Operating Profit (Loss)
|
|
$
|
44
|
|
|
$
|
23
|
|
|
$
|
(203
|
)
|
|
$
|
35
|
|
|
CHEMTURA CORPORATION
|
|
Major Factors Affecting Net Sales and Operating Results
(Unaudited)
|
|
Quarter and Nine Months Ended September 30, 2008 versus 2007
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table summarizes the major factors contributing to the
changes in operating results versus the prior year:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended
|
|
|
Nine Months Ended
|
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
|
|
|
|
Pre-tax
|
|
|
|
|
|
Pre-tax
|
|
|
|
|
|
|
|
Earnings
|
|
|
|
|
|
Earnings
|
|
|
|
|
|
|
|
(Loss) from
|
|
|
|
|
|
(Loss) from
|
|
|
|
|
Net
|
|
|
Continuing
|
|
|
Net
|
|
|
Continuing
|
|
|
|
|
Sales
|
|
|
Operations
|
|
|
Sales
|
|
|
Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
$
|
929
|
|
|
$
|
(5
|
)
|
|
$
|
2,856
|
|
|
$
|
(43
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 Accelerated recognition of asset retirement obligation
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
7
|
|
|
2007 Accelerated depreciation of property, plant and equipment
|
|
|
-
|
|
|
|
10
|
|
|
|
-
|
|
|
|
46
|
|
|
2007 Facility closures, severance and related costs
|
|
|
-
|
|
|
|
9
|
|
|
|
-
|
|
|
|
34
|
|
|
2007 Antitrust costs
|
|
|
-
|
|
|
|
2
|
|
|
|
-
|
|
|
|
32
|
|
|
2007 Gain (loss) on sale of business
|
|
|
-
|
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
14
|
|
|
2007 Impairment of long-lived assets
|
|
|
-
|
|
|
|
9
|
|
|
|
-
|
|
|
|
16
|
|
|
|
|
|
929
|
|
|
|
24
|
|
|
|
2,856
|
|
|
|
106
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Higher selling prices
|
|
|
59
|
|
|
|
59
|
|
|
|
105
|
|
|
|
105
|
|
|
Unit volume and mix
|
|
|
(16
|
)
|
|
|
(1
|
)
|
|
|
(37
|
)
|
|
|
4
|
|
|
Foreign currency impact
|
|
|
15
|
|
|
|
4
|
|
|
|
70
|
|
|
|
6
|
|
|
Acquisitions
|
|
|
-
|
|
|
|
-
|
|
|
|
20
|
|
|
|
4
|
|
|
Divestitures
|
|
|
(63
|
)
|
|
|
(5
|
)
|
|
|
(158
|
)
|
|
|
(5
|
)
|
|
Manufacturing variances
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(8
|
)
|
|
Higher raw materials/energy costs
|
|
|
-
|
|
|
|
(67
|
)
|
|
|
-
|
|
|
|
(141
|
)
|
|
Reductions in SGA&R, excluding foreign exchange impact
|
|
|
-
|
|
|
|
13
|
|
|
|
-
|
|
|
|
45
|
|
|
Lower A/R securitization fees
|
|
|
-
|
|
|
|
1
|
|
|
|
-
|
|
|
|
3
|
|
|
Higher foreign exchange gains
|
|
|
-
|
|
|
|
5
|
|
|
|
-
|
|
|
|
16
|
|
|
Higher interest income
|
|
|
-
|
|
|
|
2
|
|
|
|
-
|
|
|
|
2
|
|
|
Lower minority interest expense
|
|
|
-
|
|
|
|
2
|
|
|
|
-
|
|
|
|
3
|
|
|
Lease accounting
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(7
|
)
|
|
Lower interest expense
|
|
|
-
|
|
|
|
1
|
|
|
|
-
|
|
|
|
8
|
|
|
Other
|
|
|
-
|
|
|
|
3
|
|
|
|
-
|
|
|
|
4
|
|
|
|
|
|
924
|
|
|
|
41
|
|
|
|
2,856
|
|
|
|
145
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008 Accelerated recognition of asset retirement obligation
|
|
|
-
|
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
(3
|
)
|
|
2008 Insurance recovery
|
|
|
-
|
|
|
|
2
|
|
|
|
-
|
|
|
|
5
|
|
|
2008 Pension curtailment / settlement
|
|
|
-
|
|
|
|
(3
|
)
|
|
|
-
|
|
|
|
4
|
|
|
2008 Accelerated depreciation of property, plant and equipment
|
|
|
-
|
|
|
|
(8
|
)
|
|
|
-
|
|
|
|
(39
|
)
|
|
2008 Antitrust costs
|
|
|
-
|
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
(12
|
)
|
|
2008 Loss on sale of business
|
|
|
-
|
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
(25
|
)
|
|
2008 Impairment of long-lived assets
|
|
|
-
|
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
(321
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
$
|
924
|
|
|
$
|
28
|
|
|
$
|
2,856
|
|
|
$
|
(246
|
)
|
|
CHEMTURA CORPORATION
|
|
Managed Basis Consolidated Statements of Operations (Unaudited)
|
|
(In millions, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended September 30, 2008
|
|
|
Quarter Ended September 30, 2007
|
|
|
|
|
GAAP
|
|
|
Managed Basis
Adjustment
|
|
|
Managed
Basis
|
|
|
GAAP
|
|
|
Managed Basis
Adjustment
|
|
|
Managed
Basis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
924
|
|
|
$
|
-
|
|
|
$
|
924
|
|
|
$
|
929
|
|
|
$
|
-
|
|
|
$
|
929
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold
|
|
|
731
|
|
|
|
1
|
|
|
|
732
|
|
|
|
727
|
|
|
|
-
|
|
|
|
727
|
|
|
Selling, general and administrative
|
|
|
80
|
|
|
|
(3
|
)
|
|
|
77
|
|
|
|
87
|
|
|
|
-
|
|
|
|
87
|
|
|
Depreciation and amortization
|
|
|
54
|
|
|
|
(8
|
)
|
|
|
46
|
|
|
|
59
|
|
|
|
(10
|
)
|
|
|
49
|
|
|
Research and development
|
|
|
12
|
|
|
|
-
|
|
|
|
12
|
|
|
|
15
|
|
|
|
-
|
|
|
|
15
|
|
|
Facility closures, severance and related costs
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
9
|
|
|
|
(9
|
)
|
|
|
-
|
|
|
Antitrust costs
|
|
|
1
|
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
2
|
|
|
|
(2
|
)
|
|
|
-
|
|
|
Loss (gain) on sale of business
|
|
|
1
|
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
(1
|
)
|
|
|
1
|
|
|
|
-
|
|
|
Impairment of long-lived assets
|
|
|
1
|
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
9
|
|
|
|
(9
|
)
|
|
|
-
|
|
|
Equity income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit
|
|
|
44
|
|
|
|
13
|
|
|
|
57
|
|
|
|
23
|
|
|
|
29
|
|
|
|
52
|
|
|
Interest expense
|
|
|
(20
|
)
|
|
|
-
|
|
|
|
(20
|
)
|
|
|
(21
|
)
|
|
|
-
|
|
|
|
(21
|
)
|
|
Other income (expense), net
|
|
|
4
|
|
|
|
-
|
|
|
|
4
|
|
|
|
(7
|
)
|
|
|
-
|
|
|
|
(7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) from continuing operations before income taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28
|
|
|
|
13
|
|
|
|
41
|
|
|
|
(5
|
)
|
|
|
29
|
|
|
|
24
|
|
|
Income tax (expense) benefit
|
|
|
(17
|
)
|
|
|
2
|
|
|
|
(15
|
)
|
|
|
6
|
|
|
|
(14
|
)
|
|
|
(8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings from continuing operations
|
|
|
11
|
|
|
|
15
|
|
|
|
26
|
|
|
|
1
|
|
|
|
15
|
|
|
|
16
|
|
|
Earnings from discontinued operations
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
3
|
|
|
|
-
|
|
|
|
3
|
|
|
Loss on sale of discontinued operations
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(2
|
)
|
|
|
2
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
11
|
|
|
$
|
15
|
|
|
$
|
26
|
|
|
$
|
2
|
|
|
$
|
17
|
|
|
$
|
19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings from continuing operations
|
|
|
|
|
|
|
|
$
|
0.11
|
|
|
|
|
|
|
|
|
$
|
0.07
|
|
|
Diluted earnings from discontinued operations
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
0.01
|
|
|
Diluted net earnings
|
|
|
|
|
|
|
|
$
|
0.11
|
|
|
|
|
|
|
|
|
$
|
0.08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted average shares outstanding
|
|
|
|
|
|
|
|
|
242.4
|
|
|
|
|
|
|
|
|
|
241.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter
Ended
September 30, 2008
|
|
|
|
|
|
|
|
|
Quarter
Ended
September 30, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Managed Basis Adjustments consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accelerated recognition of asset retirement obligation
|
|
|
|
|
$
|
1
|
|
|
|
|
|
|
|
|
$
|
-
|
|
|
|
|
|
Insurance recovery
|
|
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
Pension curtailment / settlement
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
Accelerated depreciation of property, plant and equipment
|
|
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
10
|
|
|
|
|
|
Facility closures, severance and related costs
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
|
|
Antitrust costs
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
Loss (gain) on sale of business
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
Impairment of long-lived assets
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
|
|
Pre-Tax
|
|
|
|
|
|
13
|
|
|
|
|
|
|
|
|
|
29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustment to apply a managed basis effective tax rate
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
(14
|
)
|
|
|
|
|
After-Tax
|
|
|
|
|
|
15
|
|
|
|
|
|
|
|
|
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on sale of discontinued operations
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
Net earnings
|
|
|
|
|
$
|
15
|
|
|
|
|
|
|
|
|
$
|
17
|
|
|
|
|
|
CHEMTURA CORPORATION
|
|
Managed Basis Consolidated Statements of Operations (Unaudited)
|
|
(In millions, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2008
|
|
|
Nine Months Ended September 30, 2007
|
|
|
|
|
|
|
|
Managed Basis
Adjustment
|
|
|
Managed
Basis
|
|
|
|
|
|
Managed Basis
Adjustment
|
|
|
Managed
Basis
|
|
|
|
|
GAAP
|
|
|
|
|
|
|
GAAP
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
2,856
|
|
|
$
|
-
|
|
|
$
|
2,856
|
|
|
$
|
2,856
|
|
|
$
|
-
|
|
|
$
|
2,856
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold
|
|
|
2,231
|
|
|
|
2
|
|
|
|
2,233
|
|
|
|
2,197
|
|
|
|
(7
|
)
|
|
|
2,190
|
|
|
Selling, general and administrative
|
|
|
253
|
|
|
|
4
|
|
|
|
257
|
|
|
|
292
|
|
|
|
-
|
|
|
|
292
|
|
|
Depreciation and amortization
|
|
|
180
|
|
|
|
(39
|
)
|
|
|
141
|
|
|
|
192
|
|
|
|
(46
|
)
|
|
|
146
|
|
|
Research and development
|
|
|
40
|
|
|
|
-
|
|
|
|
40
|
|
|
|
46
|
|
|
|
-
|
|
|
|
46
|
|
|
Facility closures, severance and related costs
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
34
|
|
|
|
(34
|
)
|
|
|
-
|
|
|
Antitrust costs
|
|
|
12
|
|
|
|
(12
|
)
|
|
|
-
|
|
|
|
32
|
|
|
|
(32
|
)
|
|
|
-
|
|
|
Loss on sale of business
|
|
|
25
|
|
|
|
(25
|
)
|
|
|
-
|
|
|
|
14
|
|
|
|
(14
|
)
|
|
|
-
|
|
|
Impairment of long-lived assets
|
|
|
321
|
|
|
|
(321
|
)
|
|
|
-
|
|
|
|
16
|
|
|
|
(16
|
)
|
|
|
-
|
|
|
Equity income
|
|
|
(3
|
)
|
|
|
-
|
|
|
|
(3
|
)
|
|
|
(2
|
)
|
|
|
-
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating (loss) profit
|
|
|
(203
|
)
|
|
|
391
|
|
|
|
188
|
|
|
|
35
|
|
|
|
149
|
|
|
|
184
|
|
|
Interest expense
|
|
|
(59
|
)
|
|
|
-
|
|
|
|
(59
|
)
|
|
|
(67
|
)
|
|
|
-
|
|
|
|
(67
|
)
|
|
Other income (expense), net
|
|
|
16
|
|
|
|
-
|
|
|
|
16
|
|
|
|
(11
|
)
|
|
|
-
|
|
|
|
(11
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) earnings from continuing operations before income taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(246
|
)
|
|
|
391
|
|
|
|
145
|
|
|
|
(43
|
)
|
|
|
149
|
|
|
|
106
|
|
|
Income tax (expense) benefit
|
|
|
(37
|
)
|
|
|
(14
|
)
|
|
|
(51
|
)
|
|
|
1
|
|
|
|
(39
|
)
|
|
|
(38
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) earnings from continuing operations
|
|
|
(283
|
)
|
|
|
377
|
|
|
|
94
|
|
|
|
(42
|
)
|
|
|
110
|
|
|
|
68
|
|
|
Earnings from discontinued operations
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
14
|
|
|
|
-
|
|
|
|
14
|
|
|
Gain on sale of discontinued operations
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
25
|
|
|
|
(25
|
)
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) earnings
|
|
$
|
(283
|
)
|
|
$
|
377
|
|
|
$
|
94
|
|
|
$
|
(3
|
)
|
|
$
|
85
|
|
|
$
|
82
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings from continuing operations
|
|
|
|
|
|
|
|
$
|
0.39
|
|
|
|
|
|
|
|
|
$
|
0.28
|
|
|
Diluted earnings from discontinued operations
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
0.06
|
|
|
Diluted net earnings
|
|
|
|
|
|
|
|
$
|
0.39
|
|
|
|
|
|
|
|
|
$
|
0.34
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted average shares outstanding
|
|
|
|
|
|
|
|
242.3
|
|
|
|
|
|
|
|
|
|
242.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months
Ended
September 30, 2008
|
|
|
|
|
|
|
|
|
Nine Months
Ended
September 30, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Managed Basis Adjustments consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accelerated recognition of asset retirement obligation
|
|
|
|
|
$
|
3
|
|
|
|
|
|
|
|
|
$
|
7
|
|
|
|
|
|
Insurance recovery
|
|
|
|
|
|
(5
|
)
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
Pension curtailment / settlement
|
|
|
|
|
|
(4
|
)
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
Accelerated depreciation of property, plant and equipment
|
|
|
|
|
39
|
|
|
|
|
|
|
|
|
|
46
|
|
|
|
|
|
Facility closures, severance and related costs
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
34
|
|
|
|
|
|
Antitrust costs
|
|
|
|
|
|
12
|
|
|
|
|
|
|
|
|
|
32
|
|
|
|
|
|
Loss on sale of business
|
|
|
|
|
|
25
|
|
|
|
|
|
|
|
|
|
14
|
|
|
|
|
|
Impairment of long-lived assets
|
|
|
|
|
|
321
|
|
|
|
|
|
|
|
|
|
16
|
|
|
|
|
|
Pre-Tax
|
|
|
|
|
|
391
|
|
|
|
|
|
|
|
|
|
149
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustment to apply a managed basis effective tax rate
|
|
|
|
|
|
(14
|
)
|
|
|
|
|
|
|
|
|
(39
|
)
|
|
|
|
|
After-Tax
|
|
|
|
|
|
377
|
|
|
|
|
|
|
|
|
|
110
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on sale of discontinued operations
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
(25
|
)
|
|
|
|
|
Net earnings
|
|
|
|
|
$
|
377
|
|
|
|
|
|
|
|
|
$
|
85
|
|
|
|
|
|
CHEMTURA CORPORATION
|
|
Managed Basis Segment Net Sales and Operating Profit (Loss)
(Unaudited)
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended September 30, 2008
|
|
|
Quarter Ended September 30, 2007
|
|
|
|
|
|
|
|
Managed Basis
|
|
|
Managed
|
|
|
|
|
|
Managed Basis
|
|
|
Managed
|
|
|
|
|
GAAP
|
|
|
Adjustments
|
|
|
Basis
|
|
|
GAAP
|
|
|
Adjustments
|
|
|
Basis
|
|
NET SALES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Polymer Additives
|
|
$
|
414
|
|
|
$
|
-
|
|
|
$
|
414
|
|
|
$
|
447
|
|
|
$
|
-
|
|
|
$
|
447
|
|
|
Performance Specialties
|
|
|
271
|
|
|
|
-
|
|
|
|
271
|
|
|
|
237
|
|
|
|
-
|
|
|
|
237
|
|
|
Consumer Products
|
|
|
121
|
|
|
|
-
|
|
|
|
121
|
|
|
|
139
|
|
|
|
-
|
|
|
|
139
|
|
|
Crop Protection
|
|
|
103
|
|
|
|
-
|
|
|
|
103
|
|
|
|
83
|
|
|
|
-
|
|
|
|
83
|
|
|
Other
|
|
|
15
|
|
|
|
-
|
|
|
|
15
|
|
|
|
23
|
|
|
|
-
|
|
|
|
23
|
|
|
Total Net Sales
|
|
$
|
924
|
|
|
$
|
-
|
|
|
$
|
924
|
|
|
$
|
929
|
|
|
$
|
-
|
|
|
$
|
929
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING PROFIT (LOSS)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Polymer Additives
|
|
$
|
14
|
|
|
$
|
(1
|
)
|
|
$
|
13
|
|
|
$
|
7
|
|
|
$
|
8
|
|
|
$
|
15
|
|
|
Performance Specialties
|
|
|
31
|
|
|
|
-
|
|
|
|
31
|
|
|
|
28
|
|
|
|
-
|
|
|
|
28
|
|
|
Consumer Products
|
|
|
16
|
|
|
|
-
|
|
|
|
16
|
|
|
|
20
|
|
|
|
-
|
|
|
|
20
|
|
|
Crop Protection
|
|
|
18
|
|
|
|
-
|
|
|
|
18
|
|
|
|
11
|
|
|
|
-
|
|
|
|
11
|
|
|
Other
|
|
|
1
|
|
|
|
1
|
|
|
|
2
|
|
|
|
1
|
|
|
|
1
|
|
|
|
2
|
|
|
|
|
|
80
|
|
|
|
-
|
|
|
|
80
|
|
|
|
67
|
|
|
|
9
|
|
|
|
76
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General corporate expense, including amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(25
|
)
|
|
|
2
|
|
|
|
(23
|
)
|
|
|
(24
|
)
|
|
|
-
|
|
|
|
(24
|
)
|
|
Change in useful life of property, plant and equipment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8
|
)
|
|
|
8
|
|
|
|
-
|
|
|
|
(1
|
)
|
|
|
1
|
|
|
|
-
|
|
|
Facility closures, severance and related costs
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(9
|
)
|
|
|
9
|
|
|
|
-
|
|
|
Antitrust costs
|
|
|
(1
|
)
|
|
|
1
|
|
|
|
-
|
|
|
|
(2
|
)
|
|
|
2
|
|
|
|
-
|
|
|
(Loss) gain on sale of business
|
|
|
(1
|
)
|
|
|
1
|
|
|
|
-
|
|
|
|
1
|
|
|
|
(1
|
)
|
|
|
-
|
|
|
Impairment of long-lived assets
|
|
|
(1
|
)
|
|
|
1
|
|
|
|
-
|
|
|
|
(9
|
)
|
|
|
9
|
|
|
|
-
|
|
|
Total Operating Profit
|
|
$
|
44
|
|
|
$
|
13
|
|
|
$
|
57
|
|
|
$
|
23
|
|
|
$
|
29
|
|
|
$
|
52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DEPRECIATION AND AMORTIZATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Polymer Additives
|
|
$
|
23
|
|
|
$
|
-
|
|
|
$
|
23
|
|
|
$
|
29
|
|
|
$
|
(8
|
)
|
|
$
|
21
|
|
|
Performance Specialties
|
|
|
7
|
|
|
|
-
|
|
|
|
7
|
|
|
|
6
|
|
|
|
-
|
|
|
|
6
|
|
|
Consumer Products
|
|
|
2
|
|
|
|
-
|
|
|
|
2
|
|
|
|
3
|
|
|
|
-
|
|
|
|
3
|
|
|
Crop Protection
|
|
|
2
|
|
|
|
-
|
|
|
|
2
|
|
|
|
1
|
|
|
|
-
|
|
|
|
1
|
|
|
Other
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1
|
|
|
|
-
|
|
|
|
1
|
|
|
General corporate expense, including amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20
|
|
|
|
(8
|
)
|
|
|
12
|
|
|
|
19
|
|
|
|
(2
|
)
|
|
|
17
|
|
|
Total Depreciation and Amortization
|
|
$
|
54
|
|
|
$
|
(8
|
)
|
|
$
|
46
|
|
|
$
|
59
|
|
|
$
|
(10
|
)
|
|
$
|
49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter
Ended
September 30, 2008
|
|
|
|
|
|
|
|
|
Quarter
Ended
September 30, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Managed Basis Adjustments consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accelerated recognition of asset retirement obligation
|
|
|
|
|
$
|
1
|
|
|
|
|
|
|
|
|
$
|
-
|
|
|
|
|
|
Insurance recovery
|
|
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
Pension curtailment / settlement
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
Accelerated depreciation of property, plant and equipment
|
|
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
10
|
|
|
|
|
|
Facility closures, severance and related costs
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
|
|
Antitrust costs
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
Loss (gain) on sale of business
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
Impairment of long-lived assets
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
$
|
13
|
|
|
|
|
|
|
|
|
$
|
29
|
|
|
|
|
|
CHEMTURA CORPORATION
|
|
Managed Basis Segment Net Sales and Operating Profit (Loss)
(Unaudited)
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2008
|
|
|
Nine Months Ended September 30, 2007
|
|
|
|
|
|
|
|
Managed Basis
|
|
Managed
|
|
|
|
|
|
Managed Basis
|
|
Managed
|
|
|
|
|
GAAP
|
|
|
Adjustments
|
|
Basis
|
|
|
GAAP
|
|
|
Adjustments
|
|
Basis
|
|
NET SALES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Polymer Additives
|
|
$
|
1,294
|
|
|
$
|
-
|
|
|
$
|
1,294
|
|
|
$
|
1,366
|
|
|
$
|
-
|
|
|
$
|
1,366
|
|
|
Performance Specialties
|
|
|
787
|
|
|
|
-
|
|
|
|
787
|
|
|
|
680
|
|
|
|
-
|
|
|
|
680
|
|
|
Consumer Products
|
|
|
422
|
|
|
|
-
|
|
|
|
422
|
|
|
|
456
|
|
|
|
-
|
|
|
|
456
|
|
|
Crop Protection
|
|
|
306
|
|
|
|
-
|
|
|
|
306
|
|
|
|
261
|
|
|
|
-
|
|
|
|
261
|
|
|
Other
|
|
|
47
|
|
|
|
-
|
|
|
|
47
|
|
|
|
93
|
|
|
|
-
|
|
|
|
93
|
|
|
Total Net Sales
|
|
$
|
2,856
|
|
|
$
|
-
|
|
|
$
|
2,856
|
|
|
$
|
2,856
|
|
|
$
|
-
|
|
|
$
|
2,856
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING PROFIT (LOSS)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Polymer Additives
|
|
$
|
49
|
|
|
$
|
15
|
|
|
$
|
64
|
|
|
$
|
64
|
|
|
$
|
9
|
|
|
$
|
73
|
|
|
Performance Specialties
|
|
|
88
|
|
|
|
1
|
|
|
|
89
|
|
|
|
82
|
|
|
|
-
|
|
|
|
82
|
|
|
Consumer Products
|
|
|
49
|
|
|
|
-
|
|
|
|
49
|
|
|
|
56
|
|
|
|
-
|
|
|
|
56
|
|
|
Crop Protection
|
|
|
63
|
|
|
|
-
|
|
|
|
63
|
|
|
|
40
|
|
|
|
-
|
|
|
|
40
|
|
|
Other
|
|
|
2
|
|
|
|
1
|
|
|
|
3
|
|
|
|
(3
|
)
|
|
|
5
|
|
|
|
2
|
|
|
|
|
|
251
|
|
|
|
17
|
|
|
|
268
|
|
|
|
239
|
|
|
|
14
|
|
|
|
253
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General corporate expense, including
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization
|
|
|
(72
|
)
|
|
|
(8
|
)
|
|
|
(80
|
)
|
|
|
(71
|
)
|
|
|
2
|
|
|
|
(69
|
)
|
|
Change in useful life of property, plant and equipment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(24
|
)
|
|
|
24
|
|
|
|
-
|
|
|
|
(37
|
)
|
|
|
37
|
|
|
|
-
|
|
|
Facility closures, severance and related costs
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(34
|
)
|
|
|
34
|
|
|
|
-
|
|
|
Antitrust costs
|
|
|
(12
|
)
|
|
|
12
|
|
|
|
-
|
|
|
|
(32
|
)
|
|
|
32
|
|
|
|
-
|
|
|
Loss on sale of business
|
|
|
(25
|
)
|
|
|
25
|
|
|
|
-
|
|
|
|
(14
|
)
|
|
|
14
|
|
|
|
-
|
|
|
Impairment of long-lived assets
|
|
|
(321
|
)
|
|
|
321
|
|
|
|
-
|
|
|
|
(16
|
)
|
|
|
16
|
|
|
|
-
|
|
|
Total Operating (Loss) Profit
|
|
$
|
(203
|
)
|
|
$
|
391
|
|
|
$
|
188
|
|
|
$
|
35
|
|
|
$
|
149
|
|
|
$
|
184
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DEPRECIATION AND AMORTIZATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Polymer Additives
|
|
$
|
83
|
|
|
$
|
(14
|
)
|
|
$
|
69
|
|
|
$
|
72
|
|
|
$
|
(8
|
)
|
|
$
|
64
|
|
|
Performance Specialties
|
|
|
21
|
|
|
|
(1
|
)
|
|
|
20
|
|
|
|
17
|
|
|
|
-
|
|
|
|
17
|
|
|
Consumer Products
|
|
|
8
|
|
|
|
-
|
|
|
|
8
|
|
|
|
10
|
|
|
|
-
|
|
|
|
10
|
|
|
Crop Protection
|
|
|
6
|
|
|
|
-
|
|
|
|
6
|
|
|
|
3
|
|
|
|
-
|
|
|
|
3
|
|
|
Other
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
3
|
|
|
|
-
|
|
|
|
3
|
|
|
General corporate expense, including amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
62
|
|
|
|
(24
|
)
|
|
|
38
|
|
|
|
87
|
|
|
|
(38
|
)
|
|
|
49
|
|
|
Total Depreciation and Amortization
|
|
$
|
180
|
|
|
$
|
(39
|
)
|
|
$
|
141
|
|
|
$
|
192
|
|
|
$
|
(46
|
)
|
|
$
|
146
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months
Ended
September 30, 2008
|
|
|
|
|
|
|
|
|
Nine Months
Ended
September 30, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Managed Basis Adjustments consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accelerated recognition of asset retirement obligation
|
|
|
|
|
$
|
3
|
|
|
|
|
|
|
|
|
$
|
7
|
|
|
|
|
|
Insurance recovery
|
|
|
|
|
|
(5
|
)
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
Pension curtailment / settlement
|
|
|
|
|
|
(4
|
)
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
Accelerated depreciation of property, plant and equipment
|
|
|
|
|
|
39
|
|
|
|
|
|
|
|
|
|
46
|
|
|
|
|
|
Facility closures, severance and related costs
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
34
|
|
|
|
|
|
Antitrust costs
|
|
|
|
|
|
12
|
|
|
|
|
|
|
|
|
|
32
|
|
|
|
|
|
Loss on sale of business
|
|
|
|
|
|
25
|
|
|
|
|
|
|
|
|
|
14
|
|
|
|
|
|
Impairment of long-lived assets
|
|
|
|
|
|
321
|
|
|
|
|
|
|
|
|
|
16
|
|
|
|
|
|
|
|
|
|
|
$
|
391
|
|
|
|
|
|
|
|
|
$
|
149
|
|
|
|
|